This article examines the impact of obesity and metabolic disorders on the risk of developing oncological diseases in women. The mechanisms of the influence of excess weight, insulin resistance, chronic inflammation, and hormonal changes on carcinogenesis are analyzed. Modern epidemiological research data are presented, and possible preventive measures are discussed.

Obesity, Metabolic Disorders, Oncological Diseases, Women’s Health, Cancer Risk,

World Health Organization. Obesity and Cancer Risk. Geneva: WHO, 2022.

Calle E. E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms // Nature Reviews Cancer. 2004. Vol. 4. No. 8. P. 579-591.

Renehan A. G., Tyson M., Egger M., Heller R. F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies // The Lancet. 2008. Vol. 371. No. 9612. P. 569-578.

Esposito K., Chiodini P., Colao A., Lenzi A., Giugliano D. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis // Diabetes Care. 2012. Vol. 35. No. 11. P. 2402-2411.

Iyengar N. M., Gucalp A., Dannenberg A. J., Hudis C. A. Obesity and cancer mechanisms: tumor microenvironment and inflammation // Journal of Clinical Oncology. 2016. Vol. 34. No. 35. P. 4270-4276.